![](/img/cover-not-exists.png)
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy
Wen, Patrick Y, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, CLanguage:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nox154
Date:
August, 2017
File:
PDF, 284 KB
english, 2017